Edition:
United States

Express Scripts Holding Co (ESRX.O)

ESRX.O on Nasdaq

67.21USD
12:13pm EDT
Change (% chg)

$0.75 (+1.13%)
Prev Close
$66.46
Open
$67.27
Day's High
$67.45
Day's Low
$66.97
Volume
1,322,109
Avg. Vol
4,154,968
52-wk High
$80.02
52-wk Low
$63.22

Select another date:

Tue, Apr 4 2017

BRIEF-Express Scripts lowers prescription drug spending for workers' compensation payers

* Express Scripts Holding Co says lowered prescription drug spending for workers' compensation payers by 7.6 percent in 2016

Judge dismisses two Express Scripts claims in Anthem drug pricing lawsuit

NEW YORK A federal judge has dismissed two of the six counterclaims that pharmacy benefits manager Express Scripts Holding Co raised in health insurer's Anthem Inc's $15 billion lawsuit claiming it charged too much for drugs.

Judge dismisses two Express Scripts claims in Anthem drug pricing lawsuit

NEW YORK A federal judge has dismissed two of the six counterclaims that pharmacy benefits manager Express Scripts Holding Co raised in health insurer's Anthem Inc's $15 billion lawsuit claiming it charged too much for drugs.

BRIEF-US judge dismisses two Express Scripts counterclaims in Anthem lawsuit

March 24 * U.S. JUDGE DISMISSES TWO COUNTERCLAIMS THAT EXPRESS SCRIPTS RAISED IN $15 BLN ANTHEM INC LAWSUIT ALLEGING BREACH OF PHARMACY BENEFIT MANAGEMENT AGREEMENT--COURT RULING

Judge dismisses two Express Scripts claims in Anthem drug pricing lawsuit

NEW YORK, March 24 A federal judge has dismissed two of the six counterclaims that pharmacy benefits manager Express Scripts Holding Co raised in health insurer's Anthem Inc's $15 billion lawsuit claiming it charged too much for drugs.

BRIEF-Express Scripts CEO Timothy Wentworth's FY 2016 total compensation $14.5 mln vs $8.5 mln

* Express scripts holding co - ceo timothy wentworth's fy 2016 total compensation $14.5 million versus $8.5 million in fy 2015 - sec filing

Express Scripts says Amgen data opens door to patients

NEW YORK Express Scripts Holding Co Chief Medical Officer Dr. Steve Miller said on Friday that the data on heart drug Repatha from Amgen Inc was incrementally better and would change patient access to the drug.

Express Scripts says Amgen data opens door to patients

NEW YORK, March 17 Express Scripts Holding Co Chief Medical Officer Dr. Steve Miller said on Friday that the data on heart drug Repatha from Amgen Inc was incrementally better and would change patient access to the drug.

BRIEF-Express Scripts reports Q4 GAAP EPS $2.34

* Express scripts announces 2016 fourth quarter and full year results

Express Scripts says prescription drug spending slowed in 2016

Express Scripts Holding Co, the largest pharmacy benefit manager in the United States, said prescription drug spending for its members slowed to less than 4 percent in 2016, at a time when scrutiny of drug price hikes has intensified.

Select another date:

More From Around the Web